Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia

Blood

Volumn 87, Issue 2, 1996, Pages 581-591

  Farese, Ann M ^a   Herodin, Francis ^b   McKearn, John P ^b   Baum, Charles ^b   Burton, Earl ^b   MacVittie, Thomas J ^b  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN SERUM ALBUMIN; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SC 55494; SYNTHOKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW APLASIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG HALF LIFE; HEMATOPOIESIS; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

EID: 0030044584     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.2.581.bloodjournal872581     Document Type: Article

References (86)

1. Quesenberry P, Ihle JN, McGrath E: The effect of interlukin-3 and GM-CSA-2 on megakaryocyte and myeloid clonal colony formation. Blood 65-214, 1985
2. Koike K, Stanley ER, Ihle JN, Ogawa M: Macrophage colony formation supported by purified CSF-1 and/or interleukin-3 in serum-free culture: Evidence for hierarchical difference in macrophage colony-forming cells. Blood 67:859, 1986
3. Koike K, Ihle JN, Ogawa M: Declining sensitivity to interleukin-3 of murine multipotential hemopoietic progenitors during their development. J Clin Invest 77:894, 1986
4. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M: Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84:9035, 1987
5. Emerson SG, Yang YC, Clark SC, Long MW: Human recombinant granulocyte-macrophage colony stimulating factor and interleukin-3 have overlapping but distinct hematopoietic activities, J C!in Invest 82:1282, 1988
6. Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC: Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-1α. Blood 71:1759, 1988
7. Bruno E, Miller ME, Hoffman R: Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 73:671, 1989
8. Kavnoudias H, Jackson H, Ettlinger K, Bertoncello I, McNiece I, Williams N: Interleukin 3 directly stimulates both megakaryocyte progenitor cells and immature megakaryocytes. Exp Hematol 20:43, 1992
9. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P: The in vivo effects of recombinant human interleukin-3: Demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF responsive progenitors in nonhuman primates. Blood 74:613, 1989
10. Krumwieh D, Weinmann E, Sieboil B, Seiler FR: Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF, and GM-CSF in cynomolgus monkeys. Int J Cell Cloning 8-229, 1990 (suppl 1)
11. Wagemaker G, van Gils FCJM, Burger H, Dorssers LCJ, van Leen RW, Persoon NLM, Wielenga JJ, Heeney JL, Knol E: Highly increased production of bone marrow derived blood cells by administration of homologous interleukin-3 to rhesus monkeys. Blood 76:2235, 1990
12. Monroy RL, Davis TA, Donahue RE, MacVittie TJ: In vivo stimulation of platelet production in a primate model using IL-1 and IL-3. Exp Hematol 19:629, 1991
13. Stahl CP, Winton EF, Monroe MC, Haff E, Holman RC, Myers L, Liehl E, Evatl BL: Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates. Blood 80:2479, 1992
14. Geissler K, Valent P, Bettelheim P, Sillaber C, Wagner B, Kyrie P, Hinterberger W, Lechner K, Liehl E, Mayer P: In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood 79:1155, 1992
15. Gillio AP, Gasparetto C, Laver J, Abboud M, Bonilla MA, Garnick MB, O'Reilly RJ: Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. J Clin Invest 85:1560, 1990
16. Farese AM, Williams DE, Seiler FR, MacVittie TJ: Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood 82.3012, 1993
17. MacVittie TJ, Farese AM, Patchen ML, Myers LA: Therapeutic efficacy of recombinant interleukin-6 alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia. Blood 84:2515, 1994
18. Winton EF, Srinivasiah J, Kim BK, Hillyer CD, Strobert EA, Orkin JL, Swenson RB, McClure HM, Myers LA, Saral R: Effect of recombinant human interleukin-6 and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood 84:65, 1994
19. Ganser A, Seiplet G, Lindmann A, Ottmann OG, Falk S, Eder M, Herrmann F, Becher R, Höffken K, Büchner T, Klausmann M, Grisch J, Schulz G, Mertelsmann R, Hoelzer D: Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 76.455, 1990
20. Kurzrock R, Talpaz M, Estrow Z, Rosenblum MG, Gutterman JU: Phase I study of recombmant human interleukin-3 in patients with bone marrow failure. J Clin Oncol 9:1241, 1991
21. Biesma B, Willemse PH, Mulder NH, Sleijfer DT, Gietema JA, Mull R, Limburg PC, Bouma J, Vellenga E, de Vries EG: Effects of interleukin-3 after chemotherapy for advanced ovarian cancer. Blood 80:1141, 1992
22. Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, Mertelsmann R, Hoelzer D:Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: Results of a phase I study. Blood 79:2583, 1992
23. Nemunaitis J, Buckner CD, Appelbaum FR, Lilleby K, Wolff S, Bierman P, Kessinger A, Resta D, Campion M, Young DC, Zeigler A, Rosenfeld C, Shadduck RK, Singer JW: Phase I trial with recombinant human interleukin-3 (rhlL-3) in patients with lymphoid cancer undergoing autologous bone marrow transplantation (ABMT). Blood 80:85a, 1992 (abstr, suppl 1)
24. Gerhartz HH, Waltlier J, Bunica O, Klener P, Visani G, Peschle C, Huber C, Wilmanns W, Mull R, Sklenar I: Clinical-hematological-and cytokine-response to interleukin-3 (IL-3) supported chemotherapy in resistant lymphomas: A phase II study. Proc ASCO 11:329, 1992 (abstr)
25. Fibbe WE, Raemaekers J, Verdonck LF, Schouten HC, van Imhof G, Tromp B, Willemze R, van Bree J, Hessels JA, Vellenga E: Human recombinant interleukin-3 after autologous bone marrow transplantation for malignant lymphoma. Ann Oncol 3:163, 1992 (abstr. suppl 1)
26. Vellenga E, de Vries EF: Effects of interleukin-3 after chemotherapy for advanced ovarian cancer. Blood 80:1141, 1992
27. Kaushansky K, Shoemaker SG, Broudy VC, Lin NL, Matous JV, Alderman EM, Aghajanian JD, Szklut PJ, VanDyke RE, Pearce MK, Abrams JS: Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3. J Clin Invest 90:1879, 1992
28. Lopez AF, Shannon MF, Barry S, Phillips JA, Cambareri B. Dottore M, Simmons P, Vadas MA: A human interleukin 3 analog with increased biological and binding activities. Proc Natl Acad Sci USA 89:11842, 1992
29. Klein B, Olins P, Bauer C, Feng Y, Paik K, Caparon M, Thomas J, Thiele B, Klover J, Braford-Goldberg S, McKearn JP: Structure activity relationships for IL-3 and related synthokines. Blood 84:369a, 1994 (abstr. suppl 1)
30. Thomas JW, Baum CM, Hood WF, Klein B, Monahan JB, Paik K, Staten N, Abrams M, McKearn JP: Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3. Proc Natl Acad Sci USA 92-3779, 1995
31. Lotem J, Shaboy, Sachs L: Regulation of megakaryocyte development by interleukin-6. Blood 74:1545, 1989
32. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86:5953, 1989
33. Hill RJ, Warren MK, Levin J: Stimulation of thrombopoiesis in mice by human recombinant interleukin 6. J Clin Invest 85:1242, 1990
34. Quesenberry PJ, McGrath HE, Williams ME, Robinson BE, Deacon DH, Clark S, Urdal D, McNiece IK: Multifactor stimulation of megakaryocytopoiesis' Effects of interleukin-6. Exp Hematol 19:35, 1991
35. Teramura M, Shoko K, Hoshino S, Oshimi K, Mizoguchi H: Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 79:327. 1992
36. Burstein SA, Mei R-L, Henthorn J, Friese P, Turner K: Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153:305, 1992
37. Metcalf D, Hilton D, Nicola NA: Leukemia inhibitory factor can potentiate murine megakaryocytopoiesis in vitro. Blood 77.2150, 1991
38. Farese AM, Myers LA, MacVittie TJ: Therapeutic efficacy of recombinant human leukemia inhibitory factor in a primate model of radiation-induced marrow aplasia. Blood 84:3675, 1994
39. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Change MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu M C-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokme receptor Mpl. Cell 77:1117, 1994
40. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong, SC, Kaung W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddei DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand Nature 369:533, 1994
41. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
42. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kra JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
43. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopouiou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568, 1994
44. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, Hass P, Eaton D, Matthews W: In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045, 1994
45. Farese AM, Hunt P, Boone TC, MacVittie TJ Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal primates. Blood 86:54, 1995
46. Donahue RE, Seehra J, Metzger M, Lefebvre D, Rock B, Corbone S, Nathan DG, Garnick M, Seghai PK, Laston D, LaVallic E, McCoy J, Schendel PF, Norton C, Turner K, Yang YC, Clark SC: Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241:1820, 1988
47. Herodin F, Mestries JC, Janodet D, Martin S, Mathieu J, Gascon MP, Pernin MO, Ythier A: Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood 80:688, 1992
48. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F, Akiyama Y: In vivo effects of recombinant human interleukin-6 in primates: Stimulated production of platelets. Blood 75:1602, 1990
49. Metcalf D, Nicola NA, Gearing DP: Effects of injected leukemia inhibitory factor (LIF) on hemopoietic and other tissues in mice. Blood 76:50, 1990
50. Takatsuki F, Okano A, Suzuki C, Miyasaka Y, Hirano T, Kishimoto T, Ejima D, Akiyama Y. Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment. Cancer Res 50:2885, 1990
51. Mayer P, Geissler K, Valent P, Ceska M, Bettelheim P, Liehl E: Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates. Exp Hematol 19:688, 1991
52. Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF: Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates. Blood 78:1467, 1991
53. Bree A, Schlerman F, Timony G, McCarthy K, Stoudemire J, Garnick M: Pharmacokinetics and lhrombopoietic effects of recombinant human interleukin II (rhIL-11) in nonhuman primutes and rodents. Blood 78:132a, 1991 (abstr, suppl 1)
54. Patchen ML, MacVittie TJ, Williams JL, Schwanz GN, Souza LM: Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 77:472, 1991
55. Zeidler C, Kanz, L, Hurkuck, F, Rillmann KL, Wildfang I, Kadoya T, Mikayama T, Souza L, Weite K: In vivo effects (if interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 80:2740, 1992
56. Leonard J, Neben S, Quinto C, Goldman S: Recombinant human interleukin-11 (rhIL-11) stimulates progenitor cell production and accelerates peripheral platelet and hematocrit recovery in myclosuppressed mice. Blood 80:91a, 1992 (abstr. suppl 1)
57. Schlerman F, Bree A, Schaub R: Effects of subcutaneous administration of recombinant human interleukin II (rhIL-11) or recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) alone, or rhIL-11 in combination with recombinant human interleukin 3 (rhlL-3) or rhGM-CSF in nonhuman primates. Blood 80:64a. 1992 (abstr. suppl 1)
58. Burstein SA, Downs T, Friese P, Lynam S, Anderson S, Hentharn J, Epstein RB, Savage K: Thrombocytopoiesis in normal and sublethally irradiated dogs: Response to human interleukin 6. Blood 80:420, 1992
59. Neben TY, Loebelenz J, Haves L, McCarthy K, Stoudemne J, Schaub R, Goldman SJ: Recombinant human interleukin-11 stimulates megakayocvtopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 81:901, 1993
60. Mayer P, Geissler K, Ward M, Metcalf D: Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81:3226. 1993
61. Hangoc G, Yin J, Copper S, Sehendel P, Yang YC, Bronmeyer H: In vivo effects of recombinant interleukin-1 I on myelopoiesis in mice. Blood 81:965, 1993
62. Du XX, Neben S, Goldman S, Williams D: Effects of recombinant interleukin-11 on hematopoietic reconstitution in transplant mice: Acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81:27, 1993
63. Gonter PW, Hillyer CD, Strobert EA, Orkin JL, Swenson RB, McClure HM, Myers LA, Winton EF: The effect of varying ratios of administered rhIL 3 and rhGM-CSF on post-chemotherapy marrow regeneration in a nonhuman primate model. Blood 82:365a, 1993 (abstr, suppl 1)
64. Weite K, Bonilla MA, Fillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MAS, O'Reilly RJ, Souza LM: Recombinant human granulocyte colony stimulating factor: Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165:941, 1987
65. Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ: Recovery from severe hemopoietic suppression using recombinant human granulocyle-macrophage colony stimulating factor. Exp Hematol 16:334, 1988
66. Morstyn G, Campbeli L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R: Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:668, 1988
67. Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oetle D, Whitley M, Frei E III, Schnipper LE: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593, 1988
68. Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC Jr, Gilbert CJ, Oette DH: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318:869, 1988
69. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891, 1989
70. Schuening FG, Storb R, Goehle S, Graham TC, Appelbaum FR, Hackman R, Souza LM: Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 74:1308, 1989
71. MacVittie TJ, Monroy RL, Patchen ML, Souza LM: Therapeutic use of recombinant human G-CSF in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 57:723. 1990
72. Herrmann F, Ganser A, Lindemann A, Schulz G, Lubbert M, Hoeizer D, Mertelsmann R: Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: Assessment of two routes of administration. J Biol Response Mod 9:475, 1990
73. Oster W, Frisch J, Nicolay U, Schulz G: Interleukin-3: Biologie effects and clinical impact. Cancer 67:2712, 1991
74. Demetri GD, Samuels B, Gordon M, Merica EA, Mazanet R, Amman KH, Hoffman R, Young DC, Samuel S, Bukowski R: Recombinant human interleukin-6 (IL-6) increases circulating platelet counts and C-reactive protein levels in vivo: Initial results of a phase I trial in sarcoma patients with normal hemopoiesis. Blood 80:88a, 1992 (abstr, suppl 1)
75. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghusen SE, Gunn H, Mixon A, Kim H, Cole D, Levin R, Rosenberg SA: Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11:499, 1993
76. van Gameren MM, Willemse PHB, Mulder NH, Liraburg PC, Groen HJM, Vellenga E, deVries EGE: Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study. Blood 84:1434, 1994
77. Carrington PA, Hill RJ, Levin J, Verotta D: Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil. Exp Hematol 20:462, 1992
78. Williams DE, Dunn JT, Park LS, Frieden EA, Seiler FR, Farese AM, MacVittie TJ: A GM-CSF/IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys. Biotechnol Ther 4:17. 1993
79. Collins MK, Marvel J, Malde P, Lopez-Rivas A: Interleukin-3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 176:1043, 1992
80. Bodine DM, Orlic D, Birkett NC, Seidel NE: Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6. and in vivo in Sl/Sld mice as a single factor. Blood 79:913, 1992
81. Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematoposetic progenitor cells. Blood 83:1507, 1994
82. Yee NS, Paek I, Besmer P: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 179:1777, 1994
83. Ottman OG, Ganser A, Seipelt G Eder M, Shulz G, Hoelzer D: Effects, of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood 76:1494, 1990
84. Aglietta M, Sanavio F, Stacchini A, Morelli S, Fubini L, Severino A, Pasquino P, Volta C, Bretti S, Tafuto S, Zola P, Sismondi P, Sklenar I, Piacibello W, Bussolino F, Gavosto F: Interleukin-3 in vivo: Kinetic of response of target cells. Blood 82:2054. 1993
85. van Gils FCJM, Budel LM, Burger H. van Leen RW, Lowenberg B, Wagemaker G: Interleukin-3 receptors on rhesus monkey bone marrow cells: Species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. Exp Hematol 22:248, 1994
86. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Hematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990.